Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Josh Forsythe and Mark Pottle

Premium

Knome has hired Josh Forsythe as its new vice president of sales and marketing. He joins the company after 10 years at Golden Helix, where held several positions including VP of business development, VP of sales and marketing, and director of marketing.


GNS Healthcare has hired Mark Pottle to be its chief financial officer.

Prior to joining GNS, Pottle was the CFO at N-of-One. Before that, he was CFO for UnitedHealth Group's Optum Insight – Accountable Care Business Unit. He has also been vice president of finance and VP of business operations at healthcare IT company Picis, which was acquired by Optum.


The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.